ABT Abbott Laboratories
Stable Earnings Power
B 72.7 / 100 composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

Profitability

Weight: 20%
C 51
  • 5yr Avg ROIC 10.8%
  • Operating Margin Trend -0.93 pp/yr

Capital Efficiency

Weight: 15%
A- 83
  • 5yr Avg ROE 18.8%
  • 5yr Share-Count CAGR -0.4%

Growth Quality

Weight: 15%
B- 68
  • 5yr Revenue CAGR 5.1%
  • 5yr EPS CAGR 8.3%
  • Revenue-Growth Years (5) 4/5

Cash Generation

Weight: 15%
A 90
  • 5yr FCF Margin 16.5%
  • 5yr FCF/NI Conversion 0.97x

Balance Sheet

Weight: 20%
A+ 95
  • Net Debt / EBITDA 0.51x
  • Interest Coverage (EBIT/Int) 25.83x
  • Altman Z-Score 4.92

Stability

Weight: 15%
C- 47
  • EPS Volatility (σ/μ) 0.67
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 6

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

5 of 5 gurus held; 2 added; 2 trimmed; 1 full exit.

Holders
5
Avg Δ position
+1.8%
New buys
0
Full exits
1
As of Q2 2026